All news

Elan cuts jobs, shelves biofacility

Elan cuts jobs, shelves biofacility

By Phil Taylor

Faced with a tougher operating environment, Irish drugmaker Elan has decided to slash staff numbers by 230 – or around 14 per cent of its total workforce – shelve the construction of a new biologics manufacturing facility and shutter fill-and-finish capacity...

Novartis comments on $490m cell-culture vaccine contract

Novartis comments on $490m cell-culture vaccine contract

By Gareth Macdonald

Late last week the US Department of Health and Human Services (HHS) awarded Novartis a $490m contract to continue work on its cell-culture influenza vaccine plant in Holly Springs, North Carolina, US. in-PharmaTechnologist spoke with Novartis spokesman...

Follow us

Products

View more

Webinars